English
/
中文
Home
Home
About us
Nav
R&D and services
Nav
Product center
Nav
News
Nav
Careers
Nav
Contact Us
Nav
Company overview
Awards & Recognitions
R&D Introduction
Generic drug R&D platform
Generic drug consistency evaluation
Innovative drug R&D platform
Biopharmaceutical R&D platform
Therapeutic antibody development platform
Clinical research platform
Safety evaluation center
Common Reagents
Sustained and controlled release preparations
Liquid preparation
External preparation
Category 4 generic drugs
Category 3 generic drugs
Innovative drug
Biopharmaceutics
therapeutic antibody
Press Releases
Industry news
Career development
Enterprise University
Career Opportunities
Campus recruitment
Product center
Common Reagents
Sustained and controlled release preparations
Liquid preparation
External preparation
Category 4 generic drugs
Category 3 generic drugs
Innovative drug
Biopharmaceutics
therapeutic antibody
Common reagents
Common reagents
副标题
LCZ696 Tablets
Zontivity，Vorapaxar Tablets
Rexulti，brexpiprazole Tablets
Januvia，Sitagliptin phosphate Tablets
ROZEREM，Ramelteon Tablets
ULORIC，Febuxostat Tablet
Suglat，Ipragliflozin L-Proline Tablets
URIADEC Tab，Topiroxostat Tablets
Isosorbide Mononitrate Sustained Release Tablets
Prev
1
Next
